GLYCOPYRROLAT-SALZE
European patent · EP2961734 · In force
Register entry
- Publication number
- EP2961734
- Application number
- EP14716654
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 28, 2014
- Published
- Jan 6, 2016
- Granted
- Sep 26, 2018
- Protection ends at the latest
- Feb 27, 2034
- Next annual fee due
- Feb 28, 2027
- IPC classes
- C07D 207/12 (2006.01)A61K 31/40 (2006.01)A61P 43/00 (2006.01)
- Priority
- US 201361770920 P 28.02.2013US 201361770925 P 28.02.2013US 201314024480 11.09.2013US 201314024484 11.09.2013
- PCT application
- PCT/US2014/019552 28.02.2014
- PCT publication
- WO2014/134510 04.09.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 6, 2025
Change
Published in Swissreg on 06.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Apr 1, 2022
Transferred
- Owner
- Dermira, Inc., 275 Middlefield Road, Suite 150, Menlo Park, CA 94025, USA → Journey Medical Corporation, 9237 E. Via de Ventura Boulevard, Suite 105, Scottsdale, AZ 85258, USA
Published in Swissreg on 01.04.2022
- Sep 26, 2018
Granted
Published in Swissreg on 26.09.2018
Parties
Holder
Inventor
Cupertino, CA 95014, US
Kokomo, IN 46901, US
West Lafayette, IN 47906, US
Redwood City, CA 94062, US
West Lafayette, IN 47906, US
Menlo Park California 94025, US
West Lafayette, IN 47906, US
West Lafayette, IN 47906, US
West Lafayette, IN 47906, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.